Ado-trastuzumab emtansine Intravenous and Selegiline Transdermal System
Determining the interaction of Ado-trastuzumab emtansine Intravenous and Selegiline Transdermal System and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ado-trastuzumab emtansine
Brand name: Kadcyla
Synonyms: Ado-trastuzumab emtansine, Ado-Trastuzumab Emtansine
Generic Name: selegiline
Brand name: Eldepryl, Zelapar, Emsam
Synonyms: Selegiline
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ado-trastuzumab emtansine Intravenous-Selenicaps-200
- Ado-trastuzumab emtansine Intravenous-Selenimin
- Ado-trastuzumab emtansine Intravenous-Selenimin-200
- Ado-trastuzumab emtansine Intravenous-Selenious Acid
- Ado-trastuzumab emtansine Intravenous-Selenious Acid Injection
- Ado-trastuzumab emtansine Intravenous-Selenium
- Selegiline Transdermal System-Adox Pak 2/100
- Selegiline Transdermal System-Adoxa
- Selegiline Transdermal System-Adoxa CK
- Selegiline Transdermal System-Adoxa Pak
- Selegiline Transdermal System-Adoxa Pak 1/100
- Selegiline Transdermal System-Adoxa Pak 1/150